Kamada Ltd. announced the appointment of Naveh Tov, M.D., Ph.D., to the position of Vice President, Clinical Development and Medical Director for Pulmonary Diseases, effective July 1, 2016. Dr. Tov has served as Kamada’s Medical Director in a part-time consultancy role since 2007. In addition to his current responsibilities as Medical Director of the Company's pulmonology area, in his new position, Dr. Tov will now also lead Kamada’s clinical development activities. Dr. Eran Schenker, Vice President and Medical Director, will continue to lead Kamada's medical affairs in all of non-pulmonary specialties, focused on Immunology and specific IgGs, such as Type-1 Diabetes, Graft vs. Host Disease (GvHD), Transplantations and Anti-Rabies IgG, as well as new initiatives. Dr. Schenker will also expand his involvement in supporting Business Development and Investors Relations. Previously, Dr. Tov served in both active hospital academic and clinical positions at Bnai Zion Medical Center, Haifa, Israel. He specializes in Internal, Pulmonary and Sleep Medicine and served as Head of the Pulmonary Unit, and as Deputy of Internal Ward C, at Bnai Zion Medical Center, for 14 years. During these years, Dr. Tov served in academia and held appointments at the Bruce Rappoport School of Medicine-Technion in Haifa, Israel.